mechanisms and requirements for the accreditation of institutional review board

Published By : Jordan Food and Drug Administration | Consultation Type : Other |

Health

Closed

Published Consultation

3/18/2026
Comment End Date

4/18/2026
Consultation Definition

4/18/2026
Consultation Results

4/30/2026

Subject of consultation
Activities
Full legal text

Objectives

This guide aims to clarify the mechanisms and requirements for the accreditation of institutional review board (IRB) committees responsible for conducting clinical studies in Jordan. It further outlines the specific requirements pertaining to these committees, including their composition, responsibilities, and the procedures governing their operations. In addition, the guide seeks to establish the necessary guidelines and conditions to ensure the administrative, financial, and operational independence of Institutional Review Board Committees operating in Jordan

Summary

A guide to clarify the mechanisms and requirements for the accreditation of institutional review board (IRB) committees responsible for conducting clinical studies in Jordan, and to outline their specific requirements, including their composition, responsibilities, and the procedures governing their work. The guide also aims to establish guidelines and conditions to ensure the administrative, financial, and operational independence of Institutional Review Boards (IRBs) operating in Jordan, enabling them to perform their role as independent ethics committees responsible for protecting the rights, safety, and well-being of participants involved in clinical studies. Furthermore, it aims to ensure the independence of Institutional Review Boards (IRBs) in accordance with the legislation of the Jordan Food and Drug Administration (JFDA) and relevant international standards. These guidelines apply to all Institutional Review Boards (IRBs) that review clinical studies and are established in accordance with the provisions of the Jordanian Clinical Studies Law of 2011